Startseite
English
Erweiterte Suche
Durchblättern nach ...
Publikationen im Überblick
Ansprechpartner
Hilfe
DOI
PMC
 |
|
|
Open Access Gold möglich sobald Verlagsversion bei der ZB eingereicht worden ist.
Circulating metabolites improve the prediction of renal impairment in patients with type 2 diabetes.
BMJ Open Diab. Res. Care 11:e003422 (2023)
Introduction Low glomerular filtration rate (GFR) is a leading cause of reduced lifespan in type 2 diabetes. Unravelling biomarkers capable to identify high-risk patients can help tackle this burden. We investigated the association between 188 serum metabolites and kidney function in type 2 diabetes and then whether the associated metabolites improve two established clinical models for predicting GFR decline in these patients. Research design and methods Two cohorts comprising 849 individuals with type 2 diabetes (discovery and validation samples) and a follow-up study of 575 patients with estimated GFR (eGFR) decline were analyzed. Results Ten metabolites were independently associated with low eGFR in the discovery sample, with nine of them being confirmed also in the validation sample (ORs range 1.3-2.4 per 1SD, p values range 1.9×10 -2 -2.5×10 -9). Of these, five metabolites were also associated with eGFR decline (ie, tiglylcarnitine, decadienylcarnitine, total dimethylarginine, decenoylcarnitine and kynurenine) (β range -0.11 to -0.19, p values range 4.8×10 -2 to 3.0×10 -3). Indeed, tiglylcarnitine and kynurenine, which captured all the information of the other three markers, improved discrimination and reclassification (all p<0.01) of two clinical prediction models of GFR decline in people with diabetes. Conclusions Further studies are needed to validate our findings in larger cohorts of different clinical, environmental and genetic background.
Altmetric
Weitere Metriken?
Zusatzinfos bearbeiten
[➜Einloggen]
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Schlagwörter
Biomarkers ; Diabetes Mellitus, Type 2 ; Inflammation ; Kidney Diseases; Chronic Kidney-disease; Plasma Metabolites; Function Decline; Risk; Mortality; Serum; Acid; Metabolomics; Kynurenine; Guidelines
ISSN (print) / ISBN
2052-4897
e-ISSN
2052-4897
Zeitschrift
BMJ Open Diabetes Research & Care
Quellenangaben
Band: 11,
Heft: 5,
Artikelnummer: e003422
Verlag
BMJ Publishing Group
Verlagsort
London
Nichtpatentliteratur
Publikationen
Begutachtungsstatus
Peer reviewed
Institut(e)
Institute of Experimental Genetics (IEG)
Förderungen
EFSD/Sanofi Grant 2017
Ricerca corrente 2022- 2023
Ministero della Salute
PNRR M4C2I1.3 Heal Italia project
Ministero dell'Istruzione dell'Universita (PRIN) 2015
Ricerca corrente 2022- 2023
Ministero della Salute
PNRR M4C2I1.3 Heal Italia project
Ministero dell'Istruzione dell'Universita (PRIN) 2015